Minglei Kang

Associate Professor, Director of Proton Physics

University of Wisconsin-Madison
Country flagUnited States

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Minglei Kang is an Associate Professor and the Director of Proton Physics at the University of Wisconsin–Madison, USA. His research focuses on advancements in proton therapy, particularly in the areas of FLASH radiotherapy and its applications in cancer treatment, including breast, head and neck, and prostate cancers. Dr. Kang has published extensively on techniques for enhancing dose delivery and sparing organs at risk in radiation therapy.

Articles (10)

Year:

2025

Year:

2025

Bragg peak FLASH radiotherapy (RT) uses a distal tracking method to eliminate exit doses and can achieve superior OAR sparing. This study explores the application of this novel method in stereotactic body radiotherapy prostate FLASH-RT. An in-house platform was developed to enable intensity-modulated proton therapy (IMPT) planning using a single-energy Bragg peak distal tracking method. The patients involved in the study were previously treated with proton stereotactic body radiotherapy (SBRT) using the pencil beam scanning (PBS) technique to 40 Gy in five fractions. FLASH plans were optimized using a four-beam arrangement to generate a dose distribution similar to the conventional opposing beams. All of the beams had a small angle of two degrees from the lateral direction to increase the dosimetry quality. Dose metrics were compared between the conventional PBS and the Bragg peak FLASH plans. The dose rate histogram (DRVH) and FLASH metrics of 40 Gy/s coverage (V40Gy/s) were investigated for the Bragg peak plans. There was no significant difference between the clinical and Bragg peak plans in rectum, bladder, femur heads, large bowel, and penile bulb dose metrics, except for Dmax. For the CTV, the FLASH plans resulted in a higher Dmax than the clinical plans (116.9% vs. 103.3%). For the rectum, the V40Gy/s reached 94% and 93% for 1 Gy dose thresholds in composite and single-field evaluations, respectively. Additionally, the FLASH ratio reached close to 100% after the application of the 5 Gy threshold in composite dose rate assessment. In conclusion, the Bragg peak distal tracking method can yield comparable plan quality in most OARs while preserving sufficient FLASH dose rate coverage, demonstrating that the ultra-high dose technique can be applied in prostate FLASH SBRT.

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Collaborators (5)

Liyong Lin

Adjunct Associate Professor

Georgia Institute of Technology

UNITED STATES
View details

Charles Simone

Professor and Chief Medical Officer

-

UNITED STATES
View details

Jenghwa Chang

Hofstra University

UNITED STATES
View details

Ying Xiao

Professor, Clinician-Educator

University of Pennsylvania

UNITED STATES
View details

Wei Liu

Professor

Mayo Clinic Arizona

UNITED STATES
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.